Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3775734
Max Phase: Preclinical
Molecular Formula: C24H24FN5O
Molecular Weight: 417.49
Molecule Type: Small molecule
Associated Items:
ID: ALA3775734
Max Phase: Preclinical
Molecular Formula: C24H24FN5O
Molecular Weight: 417.49
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Fc1ccc(-c2c[nH]c([C@H]3Cc4c([nH]c5ccccc45)[C@@H](C4CCOCC4)N3)n2)nc1
Standard InChI: InChI=1S/C24H24FN5O/c25-15-5-6-19(26-12-15)21-13-27-24(30-21)20-11-17-16-3-1-2-4-18(16)28-23(17)22(29-20)14-7-9-31-10-8-14/h1-6,12-14,20,22,28-29H,7-11H2,(H,27,30)/t20-,22-/m1/s1
Standard InChI Key: ZABCRIKQBLSAOC-IFMALSPDSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 417.49 | Molecular Weight (Monoisotopic): 417.1965 | AlogP: 4.45 | #Rotatable Bonds: 3 |
Polar Surface Area: 78.62 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 3 |
#RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 11.79 | CX Basic pKa: 7.45 | CX LogP: 3.31 | CX LogD: 2.98 |
Aromatic Rings: 4 | Heavy Atoms: 31 | QED Weighted: 0.46 | Np Likeness Score: -0.35 |
1. He S, Dobbelaar PH, Guo L, Ye Z, Liu J, Jian T, Truong Q, Shah SK, Du W, Qi H, Bakshi RK, Hong Q, Dellureficio JD, Sherer E, Pasternak A, Feng Z, Reibarkh M, Lin M, Samuel K, Reddy VB, Mitelman S, Tong SX, Chicchi GG, Tsao KL, Trusca D, Wu M, Shao Q, Trujillo ME, Fernandez G, Nelson D, Bunting P, Kerr J, Fitzgerald P, Morissette P, Volksdorf S, Eiermann GJ, Li C, Zhang BB, Howard AD, Zhou YP, Nargund RP, Hagmann WK.. (2016) SAR exploration at the C-3 position of tetrahydro-β-carboline sstr3 antagonists., 26 (6): [PMID:26898814] [10.1016/j.bmcl.2016.02.022] |
Source(1):